NeoTX is a company that develops pipeline intended to differentiate cancer immunotherapies. Its products enhance the ability of the immune system to recognize the tumor into solid tumors and clinical safety with bacterial components that are easy for the T cells to identify and directs them. The company aims to enable patients to get effective therapies to recover.